vs
Embecta Corp.（EMBC）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
Embecta Corp.的季度营收约是GIBRALTAR INDUSTRIES, INC.的1.2倍（$261.2M vs $225.0M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs -0.3%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $16.6M），过去两年Embecta Corp.的营收复合增速更高（-4.6% vs -12.3%）
Embecta Corp.是一家专注于糖尿病护理领域的全球医疗科技企业，主要设计、生产及销售胰岛素笔针、注射器、输注组件等给药装置，产品服务覆盖全球多个地区的患者、医疗机构及生物制药合作方。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
EMBC vs ROCK — 直观对比
营收规模更大
EMBC
是对方的1.2倍
$225.0M
营收增速更快
ROCK
高出25.2%
-0.3%
自由现金流更多
ROCK
多$9.6M
$16.6M
两年增速更快
EMBC
近两年复合增速
-12.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $261.2M | $225.0M |
| 净利润 | $44.1M | — |
| 毛利率 | 61.9% | 25.3% |
| 营业利润率 | 31.9% | 7.9% |
| 净利率 | 16.9% | — |
| 营收同比 | -0.3% | 24.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.74 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EMBCROCK
| Q4 25 | $261.2M | $225.0M | ||
| Q3 25 | $264.0M | $310.9M | ||
| Q2 25 | $295.5M | $309.5M | ||
| Q1 25 | $259.0M | $290.0M | ||
| Q4 24 | $261.9M | $180.1M | ||
| Q3 24 | $286.1M | $277.1M | ||
| Q2 24 | $272.5M | $273.6M | ||
| Q1 24 | $287.2M | $292.5M |
净利润EMBCROCK
| Q4 25 | $44.1M | — | ||
| Q3 25 | $26.4M | $-89.1M | ||
| Q2 25 | $45.5M | $26.0M | ||
| Q1 25 | $23.5M | $21.1M | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $14.6M | $34.0M | ||
| Q2 24 | $14.7M | $32.2M | ||
| Q1 24 | $28.9M | $24.9M |
毛利率EMBCROCK
| Q4 25 | 61.9% | 25.3% | ||
| Q3 25 | 60.0% | 26.6% | ||
| Q2 25 | 66.7% | 28.4% | ||
| Q1 25 | 63.4% | 26.8% | ||
| Q4 24 | 60.0% | 29.0% | ||
| Q3 24 | 60.7% | 29.4% | ||
| Q2 24 | 69.8% | 30.5% | ||
| Q1 24 | 64.6% | 28.9% |
营业利润率EMBCROCK
| Q4 25 | 31.9% | 7.9% | ||
| Q3 25 | 21.4% | 12.8% | ||
| Q2 25 | 31.8% | 12.8% | ||
| Q1 25 | 24.3% | 8.8% | ||
| Q4 24 | 11.0% | 13.3% | ||
| Q3 24 | 9.2% | 15.6% | ||
| Q2 24 | 20.5% | 14.9% | ||
| Q1 24 | 13.6% | 10.8% |
净利率EMBCROCK
| Q4 25 | 16.9% | — | ||
| Q3 25 | 10.0% | -28.6% | ||
| Q2 25 | 15.4% | 8.4% | ||
| Q1 25 | 9.1% | 7.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.1% | 12.3% | ||
| Q2 24 | 5.4% | 11.8% | ||
| Q1 24 | 10.1% | 8.5% |
每股收益（稀释后）EMBCROCK
| Q4 25 | $0.74 | — | ||
| Q3 25 | $0.44 | $-2.98 | ||
| Q2 25 | $0.78 | $0.87 | ||
| Q1 25 | $0.40 | — | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $0.24 | $1.11 | ||
| Q2 24 | $0.25 | $1.05 | ||
| Q1 24 | $0.50 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $201.3M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $-613.1M | $950.4M |
| 总资产 | $1.1B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资EMBCROCK
| Q4 25 | $201.3M | $115.7M | ||
| Q3 25 | $225.5M | $89.4M | ||
| Q2 25 | $230.6M | $43.3M | ||
| Q1 25 | $209.3M | $25.1M | ||
| Q4 24 | $210.0M | $269.5M | ||
| Q3 24 | $267.5M | $228.9M | ||
| Q2 24 | $275.1M | $179.1M | ||
| Q1 24 | $299.8M | $146.7M |
总债务EMBCROCK
| Q4 25 | — | $0 | ||
| Q3 25 | $1.4B | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $1.6B | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益EMBCROCK
| Q4 25 | $-613.1M | $950.4M | ||
| Q3 25 | $-650.6M | $951.8M | ||
| Q2 25 | $-669.6M | $1.0B | ||
| Q1 25 | $-736.2M | $1.0B | ||
| Q4 24 | $-768.8M | $1.0B | ||
| Q3 24 | $-738.3M | $1.0B | ||
| Q2 24 | $-763.7M | $975.7M | ||
| Q1 24 | $-769.6M | $940.2M |
总资产EMBCROCK
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $1.3B | $1.4B | ||
| Q2 24 | $1.3B | $1.4B | ||
| Q1 24 | $1.2B | $1.3B |
负债/权益比EMBCROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.2M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $16.6M | $26.2M |
| 自由现金流率自由现金流/营收 | 6.4% | 11.7% |
| 资本支出强度资本支出/营收 | 0.2% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.39× | — |
| 过去12个月自由现金流最近4个季度 | $205.8M | $120.6M |
8季度趋势，按日历期对齐
经营现金流EMBCROCK
| Q4 25 | $17.2M | $35.5M | ||
| Q3 25 | $84.0M | $73.0M | ||
| Q2 25 | $81.2M | $44.9M | ||
| Q1 25 | $31.8M | $13.7M | ||
| Q4 24 | $-5.3M | $19.9M | ||
| Q3 24 | $26.6M | $64.7M | ||
| Q2 24 | $-2.1M | $36.5M | ||
| Q1 24 | $24.3M | $53.2M |
自由现金流EMBCROCK
| Q4 25 | $16.6M | $26.2M | ||
| Q3 25 | $76.7M | $64.8M | ||
| Q2 25 | $80.8M | $27.3M | ||
| Q1 25 | $31.7M | $2.3M | ||
| Q4 24 | $-6.8M | $14.1M | ||
| Q3 24 | — | $60.5M | ||
| Q2 24 | $-11.8M | $33.5M | ||
| Q1 24 | $20.9M | $48.8M |
自由现金流率EMBCROCK
| Q4 25 | 6.4% | 11.7% | ||
| Q3 25 | 29.1% | 20.8% | ||
| Q2 25 | 27.3% | 8.8% | ||
| Q1 25 | 12.2% | 0.8% | ||
| Q4 24 | -2.6% | 7.8% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | -4.3% | 12.2% | ||
| Q1 24 | 7.3% | 16.7% |
资本支出强度EMBCROCK
| Q4 25 | 0.2% | 4.1% | ||
| Q3 25 | 2.8% | 2.6% | ||
| Q2 25 | 0.1% | 5.7% | ||
| Q1 25 | 0.0% | 3.9% | ||
| Q4 24 | 0.6% | 3.3% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | 3.6% | 1.1% | ||
| Q1 24 | 1.2% | 1.5% |
现金转化率EMBCROCK
| Q4 25 | 0.39× | — | ||
| Q3 25 | 3.18× | — | ||
| Q2 25 | 1.78× | 1.73× | ||
| Q1 25 | 1.35× | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.82× | 1.90× | ||
| Q2 24 | -0.14× | 1.13× | ||
| Q1 24 | 0.84× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMBC
| Pen Needles | $185.5M | 71% |
| Safety | $37.3M | 14% |
| Syringes | $30.7M | 12% |
| Manufacturing Facility | $4.1M | 2% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
